Abstract
Purpose
To investigate the correlation among DVH (lung dose–volume histogram) parameters, clinical factors, and grade ≥ 2 radiation pneumonitis (RP) in patients with locally advanced non-small-cell lung cancer (NSCLC) treated with three-dimensional conformal radiotherapy (3D-CRT), and the differences between patients treated with 3D-CRT alone or that combined with chemotherapy on RP.
Patients and methods
As much as 93 patients of stage III NSCLC were treated with 3D-CRT, among which 36 were treated with chemotherapy after 3D-CRT, 57 received 3D-CRT treatment alone. The radiation dose was 62.5–65 Gy (BED = 68–72.7 Gy).
Results
The morbidity of grade ≥ 2 RP was 49.5%, of which grade 2 and grade 3 were 33.3 and 16.1%, respectively. The morbidity of RP in those patients treated with chemotherapy after radiotherapy was evidently higher than that of patients treated with radiotherapy alone (61.1 vs. 42.1%). According to the single factor analysis, V5–V50 and MLD of both the ipsilateral and the whole lung were all related to the occurrence of RP; comparing grade 3 with grade 2 within the same group, except V45, V50, TV20, TV30, and TMLD, other parameters also had their statistical significance (P < 0.01); comparing the non-chemotherapy-treated group with the chemotherapy-treated group, TV30 and TV35 had their statistical significance. According to logistic regression analysis; the occurrence of RP was evidently associated with the comprehensive value of DVH parameters, chemotherapy, and gender. Chemotherapy has increased the risk of RP 7.6 times. The increase of each score in the comprehensive value of DVH parameters would increase the risk of RP 22.7 times.
Conclusion
The comprehensive values of DVH parameters, chemotherapy, and gender have independent effects on the occurrence of RP. Most of DVH parameters were associated with the occurrence of RP. The curve shape composed of multiple points in DVH parameters was more important than any single DVH parameter.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Blom-Goldman U, Svane G, Wennberg B et al (2007) Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer. Acta Oncol 46(2):187–193
Choi YW, Munden RF, Erasmus JJ et al (2004) Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics 24:985–998
Gopal R (2005) Pulmonary toxicity associated with the treatment of non-small cell lung cancer and the effects of cytoprotective strategies. Semin Oncol 32(2 Suppl 3):S55–S59
Gopal R, Tucker SL, Komaki R et al (2003) The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56:106–113
Graham MV (1997) Predicting radiation response. Int J Radiat Oncol Biol Phys 39:561–562
Hernando ML, Marks LB, Bentel GC et al (2001) Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51:650–659
Kim TH, Cho KH, Pyo HR et al (2005) Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235:208–215
Madani I, De Ruyck K, Goeminne H, De Neve W, Thierens H, Van Meerbeeck J (2007) Predicting risk of radiation-induced lung injury. J Thorac Oncol 2(9):864–874
Marks LB, Munley MT, Bentel GC et al (1997) Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39:563–570
Oetzel D, Schraube P, Hensley F et al (1995) Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33:455–460
Onishi H, Kuriyama K, Yamaguchi M et al (2003) Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage Ш non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis. Lung Cancer 40:79–84
Piotrowski T, Matecka-Nowak M, Milecki P (2005) Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Neoplasma 52(1):56–62
Rengan R, Rosenzweig KE, Venkatraman E et al (2004) Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiol Oncol Biol Phys 60:741–747
Robnett TJ, Machtay M, Vines EF et al (2004) Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 48:89–94
Schallenkamp JM, Miller RC, Brinkmann DH et al (2007) Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys 67(2):410–416
Seppenwoolde Y, Lebesque JV, De Jaeger K et al (2003) Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 56:106–113
Sim S, Rosenzweig KE, Schindelheim R et al (2001) Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 51:660–665
Tsujino K, Hirota S, Kotani Y et al (2006) Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys 64(4):1100–1105
Wang S, Liao Z, Wei X et al (2006) Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66(5):1399–1407
Weibai Y (2008) Radiation oncology, vol 4. Peking Union Medical College Publishing Company, Beijing, pp 645–652. ISBN978-7-81072-948-2
Willner J, Jost A, Baier K et al (2003) A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179:548–556
Yamashita H, Nakagawa K, Nakamura N (2007) Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2:21–32
Yorke ED, Jackson A, Rosenzweig KE et al (2002) Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54:329–339
Zhao LJ, West B, Hayman JA et al (2007) High radiation dose may reduce the negative effect of large gross tumor volume in patients with early stage non-small cell lung cancer]. Int J Radiat Oncol Biol Phys 68:103–110
Zhu XZ, Wang LH, Zhao LJ et al (2008) Impact of gross tumor volume and radiation therapy dose on survival in stage III non-small-cell lung cancer treated with three-dimensional radiation therapy. Chin J Radiat Oncol 17(1):26–29
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dang, J., Li, G., Lu, X. et al. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol 136, 1169–1178 (2010). https://doi.org/10.1007/s00432-010-0764-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-010-0764-4